Molecular cloning of hMena (ENAH) and its splice variant hMena +11a: Epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines

Cancer Research

Volumn 67, Issue 6, 2007, Pages 2657-2665

  Di Modugno, Francesca ^a   DeMonte, Lucia ^b   Balsamo, Michele ^a   Bronzi, Giovanna ^a   Nicotra, Maria Rita ^a   Alessio, Massimo ^b   Jager, Elke ^c   Condeelis, John S ^d   Santoni, Angela ^a   Natali, Pier Giorgio ^a   Nisticò, Paola ^a,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c KRANKENHAUS NORDWEST   (Germany)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEU DIFFERENTIATION FACTOR; PROTEIN MENA; SMALL INTERFERING RNA; TRASTUZUMAB; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL ADHESION; CELL LINEAGE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; METASTASIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CLONING, MOLECULAR; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HUMANS; MICROFILAMENT PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN ISOFORMS; UP-REGULATION;

EID: 34047257715     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1997     Document Type: Article

References (36)

1. Wulfkuhle JD, Sgroi DC, Krutzsch H, et al. Proteomics of human breast ductal carcinoma in situ. Cancer Res 2002;62:6740-9.
2. Wang W, Goswami S, Lapidus K, et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004;64:8585-94.
3. + T-cell immune response. Int J Cancer 2004;109:909-18.
4. Di Modugno F, Mottolese M, Di Benedetto A, et al. The cytoskeleton regulatory protein hmena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors. Clin Cancer Res 2006;12:1470-8.
5. Bear JE, Svitkina TM, Krause M, et al. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 2002;109:509-21.
6. Vasioukhin V, Bauer C, Yin M, Fuchs E. Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 2000;100:209-19.
7. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 2003;19: 541-64.
8. Barzik M, Kotova TI, Higgs HN, et al. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem 2005;280: 28653-62.
9. Scott JA, Shewan AM, den Elzen NR, Loureiro JJ, Gertler FB, Yap AS. Ena/VASP proteins can regulate distinct modes of actin organization at cadherin-adhesive contacts. Mol Biol Cell 2006;17:1085-95.
10. Thiery JP. Epithelial-mesenchymal transition in tumour progression. Nat Rev Cancer 2002;2:442-54.
11. Prehoda KE, Lee DJ, Lim WA. Structure of the enabled/VASP homology 1 domain-peptide complex: a key component in the spatial control of actin assembly. Cell 1999;97:471-80.
12. Gertler FB, Niebuhr K, Reinhard M, Wehland J, Soriano P. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 1996;87:227-39.
13. Kuhnel K, Jarchau T, Wolf E, et al. The VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat. Proc Natl Acad Sci U S A 2004;101:17027-32.
14. Loureiro JJ, Rubinson DA, Bear JE, Baltus GA, Kwiatkowski AV, Gertler FB. Critical roles of phosphorylation and actin binding motifs, but not the central proline-rich region, for Ena/vasodilator-stimulated phosphoprotein (VASP) function during cell migration. Mol Biol Cell 2002;13:2533-46.
15. Venables JP. Aberrant and alternative splicing in cancer. Cancer Res 2004;64:7647-54.
16. Tani K, Sato S, Sukezane T, et al. Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase. J Biol Chem 2003;278: 21685-92.
17. Lebrand C, Dent EW, Strasser GA, et al. Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1. Neuron 2004; 42:37-49.
18. Toyofuku T, Zhang H, Kumanogoh A, et al. Guidance of myocardial patterning in cardiac development by Sema6D reverse signaling. Nat Cell Biol 2004;6:1204-11.
19. Coppolino MG, Krause M, Hagendorff P, et al. Evidence for a molecular complex consisting of Fyb/ SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcγ receptor signaling during phagocytosis. J Cell Sci 2001;114:4307-18.
20. Krause M, Sechi AS, Konradt M, Monner D, Gertler FB, Wehland J. Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator- stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J Cell Biol 2000;149:181-94.
21. Bierne H, Miki H, Innocenti M, et al. WASP-related proteins, Abi1 and Ena/VASP are required for Listeria invasion induced by the Met receptor. J Cell Sci 2005; 118:1537-47.
22. Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 2000;19:6550-65.
23. Westermark B. The deficient density-dependent growth control of human malignant glioma cells and virus-transformed glia-like cells in culture. Int J Cancer 1973;12:438-51.
24. Nisticò P, De Berardinis P, Morrone S, et al. Generation and characterization of two human α/β T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway. J Clin Invest 1994;94:1426-31.
25. Conti A, Ricchiuto P, Iannaccone S, et al. Pigment epithelium-derived factor is differentially expressed in peripheral neuropathies. Proteomics 2005;5:4558-67.
26. Yamagata A, Kristensen DB, Takeda Y, et al. Mapping of phosphorylated proteins on two-dimensional polyacrylamide gels using protein phosphatase. Proteomics 2002;2:1267-76.
27. Urbanelli L, Massini C, Emiliani C, Orlacchio A, Bernardi G, Orlacchio A. Characterization of human Enah gene. Biochim Biophys Acta 2006;1759:99-107.
28. Rao J, Li N. Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 2004;4:345-54.
29. Bachmann C, Fischer L, Walter U, Reinhard M. The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation. J Biol Chem 1999;274: 23549-57.
30. Lambrechts A, Kwiatkowski AV, Lanier LM, et al. cAMP-dependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J Biol Chem 2000;275: 36143-51.
31. Hirai Y, Lochter A, Galosy S, Koshida S, Niwa S, Bissell MJ. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J Cell Biol 1998; 140:159-69.
32. Goswami S, Sahai E, Wyckoff JB, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005;65:5278-83.
33. Xue C, Wyckoff J, Liang F, et al. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res 2006;66:192-7.
34. Lim YP, Wong CY, Ooi LL, Druker BJ, Epstein RJ. Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs. Clin Cancer Res 2004;10:3980-7.
35. Holbro T, Hynes NE. ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 2004;44:195-217.
36. Mackay HJ, Twelves CJ. Protein kinase C: a target for anticancer drugs? Endocr Relat Cancer 2003;10:389-96.